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background: several cardiovascular diseases are characterized by an impaired O2 kinetic during exercise such as a lack of a linear increase of 
ΔVO2/ΔWork Rate (WR). We aimed at describing the frequency of ΔVO2/ΔWR flattening in a symptomatic population, characterizing its functional 
profile and testing the role of dynamic pulmonary hypertension and right ventricular contractile reserve.
Methods: We studied 136 patients referred for dyspnoea during effort (NYHA II-IV) combining cardiopulmonary exercise test (CPET) with 
simultaneous exercise-echocardiography (incremental ramp protocol).
results: ΔVO2/ΔWR flattening was observed in 36 patients (Group A) and was associated with a worse functional profile (reduced peak VO2, 
anaerobic threshold, O2 pulse, impaired VE/VCO2). At univariate analysis rest tricuspid annular plane systolic excursion (TAPSE) and several peak 
exercise variables (ejection fraction, mitral regurgitation, systolic pulmonary artery pressure (SPAP), cardiac output and TAPSE) were all impaired in 
Group A. The multivariate analysis identified exercise SPAP (OR 1.06; CI 1.01 -1.11; p=0.011) and TAPSE (OR 0.88; CI 0.8 -0.97; p= 0.013) as main 
determinants of ΔVO2/ΔWR flattening.
conclusion: In patients symptomatic for dyspnea, the occurrence of ΔVO2/ΔWR flattening reflects a significantly impaired functional phenotype 
whose main cardiac determinants are the impaired SPAP response and the reduced RV longitudinal systolic function at peak of exercise.
Flattening (n= 36) No Flattening (n= 100) Univariate Multivariate
Rest Peak Rest Peak p p p p
Left ventricular (LV) end diastolic volume indexed, ml/m2 67±28 67±24 67±33 67±33 >0.90 >0.90
LVejection fraction, % 47±14 47±17 52±16 55±17 0.12 0.03 ---
Mitral S’ TDI, cm/s 5.9±2.3 7.3±2.7 6.3±2.0 7.9±3.2 0.35 0.36
E/A, ratio 1.3±0.8 -- 1.3±0.9 -- 0.78 --
E/e’, ratio 20.8±11.5 -- 17.6±11.9 -- 0.18 --
Left atrium volume indexed, ml/m2 49±25 -- 42±25 -- 0.16 --
Right ventricular fractional area, % 41±10 41±13 42±10 45±10 0.60 0.12
TAPSE, mm 20±5 22±5 22±5 25±6 0.05 0.0029 --- 0.013
SPAP, mmHg 37±17 61±19 33±14 51±18 0.22 0.0009 0.08 0.011
LVcardiac output, L/min 4.2±1.2 7.7±2 4.5±1.5 9.0±2.8 0.39 0.001 ---
Maximal work, watt 68.5±27.7 91±40.1 0.0005 0.0005
Peak VO
2
, mL/Kg/min 13.4±3.9 18±6.6 <0.0001
Predicted Peak VO
2
, % 57.6±17.6 68.9±21.4 0.005
AT, mL/Kg/min 11.4±3.3 13.8±4.4 0.0007
Peak RER 1.5±1.8 1.2±0.1 0.32
Peak O
2
 pulse, mL/beats 8.2±2.3 10.9±3.1 <0.0001
VE/VCO
2
33.2±8 29.8±6.8 0.02
End-tidal CO
2
, mmHg 32.1±4.8 36±5.7 0.0005
HRR, beats/min 9.5±8.7 14.5±10 0.01
